KARDİYAK ARREST SONRASI HEDEFE YÖNELİK SICAKLIK YÖNETİMİ

Hedefe yönelik sıcaklık yönetimi (HYSY) 100 yıldan fazla süredir aralıklarla kullanılmaktadır; klinik pratikteki ana rolünüancak son yıllarda kazanmıştır. Nöroprotektif terapi olarak HYSY için klinik endikasyonlar erişkin hastalarda Post-kardiyak arrestsendromunu (PKAS) içermektedir. Sıcaklık kontrolü kullanılacaksa hedef sıcaklığın 32-36 °C arasında sabit olarak sürdürülmesiönerilmektedir. Kardiyak arrest sonrası optimal hedef sıcaklık, başlangıç için optimal zamanlama ve tedavi için optimum tedavisüresi ile ilişkili randomize kontrollü çalışmalar halen devam etmektedir.

Ergenoğlu: Targeted Temperature Management

Targeted temperature management (TTM) has been used perodically for over the past 100 years. However, just recently it hasgained its main power in clinical practice. Clinical indications for TTM for neuroprotective therapy includes postcardiac arrestsyndrome in adult patients. It is suggested that the constant stable temperature should be between 32-36 °C in the use of TTM.Randomised controlled studies on optimal target temperature after the cardiac arrest, optimal timing for the start and optimumtreatment time is still being continued.

PDF

___

1. Wang H, Olivero W, Wang D, Lanzino G. Cold as a therapeutic agent. Acta Neurochir (Wien) 2006; 148: 565-570.
2. Varon J, Acosta P. Therapeutic hypothermia: past, present, and future. Chest 2008; 13:1267-1274.
3. Schenone AL, Cohen A, Patarroyo G et al. Therapeutic hypothermia after cardiac arrest: A systematic review/meta-analysis exploring the impact of expanded criteria and targeted temperature. Resuscitation 2016; 108: 102-110.
4. Guly H. History of accidental hypothermia. Resuscitation 2011; 82: 122-125.
5. Nolan JP, Neumar RW, Adrie C et al. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A Scientific Statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; the Council on Stroke. Resuscitation 2008; 79: 350-379.
6. Shankaran S. Neonatal encephalopathy: treatment with hypothermia. J Neurotrauma 2009; 26: 437-443.
7. Smith TL, Bleck TP. Hypothermia and neurologic outcome in patients following cardiac arrest: should we be hot to cool off our patients? Crit Care 2002; 6:377-380.
8. Alzaga AG, Cerdan M, Varon J. Therapeutic hypothermia. Resuscitation 2006; 70: 369-380.
9. Neumar RW, Nolan JP, Adrie C et al. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, Inter American Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation 2008; 118: 2452-2483.
10. Negovsky VA. The second step in resuscitation: the treatment of the "post-resuscitation disease". Resuscitation 1972; 1: 1-7.
11. Opie LH. Reperfusion injury and its pharmacologic modification. Circulation 1989; 80: 1049-1062.
12. White BC, Grossman LI, Krause GS. Brain injury by global ischemia and reperfusion: a theoretical perspective on membrane damage and repair. Neurology 1993; 43: 1656-1665.
13. Neumar RW. Molecular mechanisms of ischemic neuronal injury. Ann Emerg Med 2000; 36: 483-506.
14. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999; 79: 1431-1568.
15. Bano D, Nicotera P. Ca2+ signals and neuronal death in brain ischemia. Stroke 2007; 38: 674-676.
16. Sundgreen C, Larsen FS, Herzog TM, Knudsen GM, Boesgaard S, Aldershvile J. Autoregulation of cerebral blood flow in patients resuscitated from cardiac arrest. Stroke 2001; 32: 128-132.
17. Nishizawa H, Kudoh I. Cerebral autoregulation is impaired in patients resuscitated after cardiac arrest. Acta Anaesthesiol Scand 1996; 40: 1149-1153.
18. Rivers EP, Wortsman J, Rady MY, Blake HC, McGeorge FT, Buderer NM. The effect of the total cumulative epinephrine administered during human CPR on hemodynamic, oxygen transport, and utilization variables in the postresuscitation period. Chest 1994; 106: 1499-1507.
19. Prengel AW, Lindner KH, Ensinger H, Grünert A. Plasma catecholamine concentrations after successful resuscitation in patients. Crit Care Med 1992; 20: 609-614.
20. Kern KB, Hilwig RW, Rhee KH, Berg RA. Myocardial dysfunction after resuscitation from cardiac arrest: an example of global myocardial stunning. J Am Coll Cardiol 1996; 28: 232-240.
21. Cerchiari EL, Safar P, Klein E, Diven W. Visceral, hematologic and bacteriologic changes and neurologic outcome after cardiac arrest in dogs: the visceral post-resuscitation syndrome. Resuscitation 1993; 25: 119-136.
22. Adams JA. Endothelium and cardiopulmonary resuscitation. Crit Care Med 2006; 34: 458-465.
23. Esmon CT. Coagulation and inflammation. J Endotoxin Res 2003; 9: 192-198.
24. Adrie C, Adib-Conquy M, Laurent I et al. Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis-like" syndrome. Circulation 2002; 106: 562-568.
25. Gando S, Nanzaki S, Morimoto Y, Kobayashi S, Kemmotsu O. Out-of-hospital cardiac arrest increases soluble vascular endothelial adhesion molecules and neutrophil elastase associated with endothelial injury. Intensive Care Med 2000; 26: 38-44.
26. Geppert A, Zorn G, Karth GD, Haumer M, Gwechenberger M, Koller-Strametz J, Heinz G, Huber K, Siostrzonek P. Soluble selectins and the systemic inflammatory response syndrome after successful cardiopulmonary resuscitation. Crit Care Med 2000; 28: 2360-2365.
27. Perman SM, Goyal M, Neumar RW, Topjian AA, Gaieski DF. Clinical applications of targeted temperature management. Chest 2014; 145: 386-393.
28. Safar P. Community-wide cardiopulmonary resuscitation. J Iowa Med Soc1964; 54: 629-635.
29. Polderman KH. Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med 2009; 37: 186-202.
30. Yenari MA, Han HS. Neuroprotective mechanisms of hypothermia in brain ischaemia. Nat Rev Neurosci 2012; 13: 267-278.
31. Nielsen N, Wetterslev J, Cronberg T et al. Targeted temperature management at 33°C versus 36°C after cardiac arrest. N Engl J Med 2013; 369: 2197-2206.
32. Nolan JP, Soar J, Cariou A et al. European Resuscitation Council and European Society of Intensive Care Medicine Guidelines for Post-resuscitation Care 2015: Section 5 of the European Resuscitation Council Guidelines for Resuscitation 2015. Resuscitation 2015; 95: 202-222